InvestorsHub Logo
Followers 4
Posts 88
Boards Moderated 0
Alias Born 12/07/2014

Re: None

Sunday, 04/23/2017 12:52:46 PM

Sunday, April 23, 2017 12:52:46 PM

Post# of 37328
GBSN could actually sell the company for their 6 assays to some major buyer interested in getting into the molecular diagnostics infectious disease market - $25-30 million is where it could go for including the notes it still owes. So I use that as a rule of thumb when considering what is a good price to buy at. Best works when no financing left or outstanding shares all converted to float.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.